SCHEMBL5928064

SCHEMBL5928064

Cc1nc(-c2ccc(-c3ccc(CN4CC[C@H](N5CCCC5)C4)cc3)cc2)no1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.46
GPR119 Q8TDV5 1/20 0.46
RAB9A P51151 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 2/20 0.44
S1PR1 P21453 7/20 0.43
HRH3 Q9Y5N1 2/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MITF O75030 1/20 0.43
L3MBTL3 Q96JM7 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MBTD1 Q05BQ5 1/20 0.43
S1PR5 Q9H228 6/20 0.43
S1PR4 O95977 5/20 0.43
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5225059 0.99 RAB9A (0.46) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5225048 0.99 RAB9A (0.46) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5224071 0.92 S1PR1 (0.47) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5220653 0.91 RAB9A (0.46) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5220668 0.91 RAB9A (0.46) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5222060 0.91 KCNH2 (0.45) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5222076 0.91 KCNH2 (0.45) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5225958 0.84 SMN1; SMN2 (0.59) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5228387 0.84 RAB9A (0.51) KCNH2GPR119RAB9ASMN1; SMN2NPC1
SCHEMBL5225149 0.83 SMN1; SMN2 (0.61) KCNH2RAB9ASMN1; SMN2NPC1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060019998-A1 Histamine-3 receptor antagonist PFIZER INC 2006-01-26 US claimed
US-20060019998-A1 Histamine-3 receptor antagonist PFIZER INC 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060019998-A1 Histamine-3 receptor antagonist HRH3, HRH4, HRH2 KCNH2 909/4885GPR119 34/4885RAB9A 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.